Altered serum microRNAs as novel diagnostic biomarkers for atypical coronary artery disease

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Wang, Jun ^a   Pei, Yinghao ^a   Zhong, Yong ^a   Jiang, Shisen ^a   Shao, Jiaqing ^a   Gong, Jianbin ^a  

^a NANJING GENERAL HOSPITAL OF NANJING MILITARY COMMAND   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 208; MICRORNA 215; MICRORNA 29B; MICRORNA 487A; MICRORNA 502; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; MESSENGER RNA;

ADULT; AGED; ARTICLE; ATYPICAL CORONARY ARTERY DISEASE; BIOINFORMATICS; BLOOD SAMPLING; CARDITIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE MARKER; FEMALE; HEART MUSCLE FIBROSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; MOLECULAR DIAGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RECEIVER OPERATING CHARACTERISTIC; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VALIDATION STUDY; BLOOD; CASE CONTROL STUDY; COMPARATIVE STUDY; DNA MICROARRAY; FOLLOW UP; GENE EXPRESSION PROFILING; GENETICS; MIDDLE AGED; PATHOLOGY; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION;

AGED; BIOMARKERS; CASE-CONTROL STUDIES; CORONARY ARTERY DISEASE; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION PROFILING; HUMANS; MALE; MICRORNAS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84908622005     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0107012     Document Type: Article

References (35)

1. Canto JG, Shlipak MG, Rogers WJ, Malmgren JA, Frederick PD, et al. (2000) Prevalence, clinical characteristics, and mortality among patients with myocardial infarction presenting without chest pain. JAMA 283: 3223-3229.
2. Horne R, James D, Petrie K, Weinman J, Vincent R (2000) Patients' interpretation of symptoms as a cause of delay in reaching hospital during acute myocardial infarction. Heart 83: 388-393.
3. Cohn PF, Fox KM, Daly C (2003) Silent myocardial ischemia. Circulation 108: 1263-1277.
4. Ambros V (2004) The functions of animal microRNAs. Nature 431: 350-355.
5. Tang Y, Zheng J, Sun Y, Wu Z, Liu Z, et al. (2009) MicroRNA-1 regulates cardiomyocyte apoptosis by targeting Bcl-2. Int Heart J 50: 377-387.
6. Shan ZX, Lin QX, Fu YH, Deng CY, Zhou ZL, et al. (2009) Upregulated expression of miR-1/miR-206 in a rat model of myocardial infarction. Biochem Biophys Res Commun 381: 597-601.
7. Xu C, Lu Y, Pan Z, Chu W, Luo X, et al. (2007) The muscle-specific microRNAs miR-1 and miR-133 produce opposing effects on apoptosis by targeting HSP60, HSP70 and caspase-9 in cardiomyocytes. J Cell Sci 120: 3045-3052.
8. Chen X, Ba Y, Ma L, Cai X, Yin Y, et al. (2008) Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 18: 997-1006.
9. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, et al. (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 105: 10513-10518.
10. Fichtlscherer S, De Rosa S, Fox H, Schwietz T, Fischer A, et al. (2010) Circulating microRNAs in patients with coronary artery disease. Circ Res 107: 677-684.
11. Widera C, Gupta SK, Lorenzen JM, Bang C, Bauersachs J, et al. (2011) Diagnostic and prognostic impact of six circulating microRNAs in acute coronary syndrome. J Mol Cell Cardiol 51: 872-875.
12. Pryor DB, Harrell FE Jr, Lee KL, Califf RM, Rosati RA (1983) Estimating the likelihood of significant coronary artery disease. Am J Med 75: 771-780.
13. Luo Y, Wang C, Chen X, Zhong T, Cai X, et al. (2013) Increased serum and urinary microRNAs in children with idiopathic nephrotic syndrome. Clin Chem 59: 658-666.
14. Liu R, Chen X, Du Y, Yao W, Shen L, et al. (2012) Serum microRNA expression profile as a biomarker in the diagnosis and prognosis of pancreatic cancer. Clin Chem 58: 610-618.
15. Wang S, Xiang J, Li Z, Lu S, Hu J, et al. (2013) A plasma microRNA panel for early detection of colorectal cancer. Int J Cancer. doi:10.1002/ijc.28136. [Epub ahead of print].
16. Lobbes MB, Kooi ME, Lutgens E, Ruiters AW, Lima Passos V, et al. (2010) Leukocyte counts, myeloperoxidase, and pregnancy-associated plasma protein a as biomarkers for cardiovascular disease: towards a multi-biomarker approach. Int J Vasc Med 2010: 726207.
17. Bartel DP (2009) MicroRNAs: target recognition and regulatory functions. Cell 136: 215-233.
18. Droste C (1990) Influence of opiate systems in pain transmission during angina pectoris. Z Kardiol 79 Suppl 3: 31-43.
19. Falcone C, Specchia G, Rondanelli R, Guasti L, Corsico G, et al. (1988) Correlation between beta-endorphin plasma levels and anginal symptoms in patients with coronary artery disease. J Am Coll Cardiol 11: 719-723.
20. Meller ST, Gebhart GF (1993) Silent ischemia: a hypothetical mechanism. Neurosci Biobehav Rev 17: 229-236.
21. Watkins LR, Wiertelak EP, Goehler LE, Smith KP, Martin D, et al. (1994) Characterization of cytokine-induced hyperalgesia. Brain Res 654: 15-26.
22. Porreca F, Lai J, Malan TP Jr (1998) Can inflammation relieve pain? Nat Med 4: 1359-1360.
23. Panerai AE, Sacerdote P (1997) Beta-endorphin in the immune system: a role at last? Immunol Today 18: 317-319.
24. Mu J, Pang Q, Guo YH, Chen JG, Zeng W, et al. (2013) Functional implications of microRNA-215 in TGF-beta1-induced phenotypic transition of mesangial cells by targeting CTNNBIP1. PLoS One 8: e58622.
25. Ait-Oufella H, Salomon BL, Potteaux S, Robertson AK, Gourdy P, et al. (2006) Natural regulatory T cells control the development of atherosclerosis in mice. Nat Med 12: 178-180.
26. Hong S, Lim S, Li AG, Lee C, Lee YS, et al. (2007) Smad7 binds to the adaptors TAB2 and TAB3 to block recruitment of the kinase TAK1 to the adaptor TRAF2. Nat Immunol 8: 504-513.
27. van Rooij E, Sutherland LB, Thatcher JE, DiMaio JM, Naseem RH, et al. (2008) Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci U S A 105: 13027-13032.
28. Liu Y, Taylor NE, Lu L, Usa K, Cowley AW Jr, et al. (2010) Renal medullary microRNAs in Dahl salt-sensitive rats: miR-29b regulates several collagens and related genes. Hypertension 55: 974-982.
29. Callis TE, Pandya K, Seok HY, Tang RH, Tatsuguchi M, et al. (2009) MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice. J Clin Invest 119: 2772-2786.
30. Wang GK, Zhu JQ, Zhang JT, Li Q, Li Y, et al. (2010) Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J 31: 659-666.
31. Vacchi-Suzzi C, Bauer Y, Berridge BR, Bongiovanni S, Gerrish K, et al. (2012) Perturbation of microRNAs in rat heart during chronic doxorubicin treatment. PLoS One 7: e40395.
32. Li C, Fang Z, Jiang T, Zhang Q, Liu C, et al. (2013) Serum microRNAs profile from genome-wide serves as a fingerprint for diagnosis of acute myocardial infarction and angina pectoris. BMC Med Genomics 6: 16.
33. Dmitriev P, Barat A, Polesskaya A, O'Connell MJ, Robert T, et al. (2013) Simultaneous miRNA and mRNA transcriptome profiling of human myoblasts reveals a novel set of myogenic differentiation-associated miRNAs and their target genes. BMC Genomics 14: 265.
34. Le Guezennec X, Brichkina A, Huang YF, Kostromina E, Han W, et al. (2012) Wip1-dependent regulation of autophagy, obesity, and atherosclerosis. Cell Metab 16: 68-80.
35. Zhai H, Song B, Xu X, Zhu W, Ju J (2013) Inhibition of autophagy and tumor growth in colon cancer by miR-502. Oncogene 32: 1570-1579.